nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—ABCG2—Teniposide—lymphatic system cancer	0.137	0.178	CbGbCtD
Hydrocortisone—ABCG2—Mitoxantrone—lymphatic system cancer	0.0956	0.125	CbGbCtD
Hydrocortisone—CYP3A5—Teniposide—lymphatic system cancer	0.0757	0.0987	CbGbCtD
Hydrocortisone—ABCG2—Vincristine—lymphatic system cancer	0.0658	0.0857	CbGbCtD
Hydrocortisone—SLCO1A2—Methotrexate—lymphatic system cancer	0.0531	0.0693	CbGbCtD
Hydrocortisone—CYP3A7—Vincristine—lymphatic system cancer	0.0486	0.0633	CbGbCtD
Hydrocortisone—CYP3A7-CYP3A51P—Vincristine—lymphatic system cancer	0.0486	0.0633	CbGbCtD
Hydrocortisone—ABCG2—Methotrexate—lymphatic system cancer	0.0398	0.0519	CbGbCtD
Hydrocortisone—CYP3A5—Vincristine—lymphatic system cancer	0.0364	0.0475	CbGbCtD
Hydrocortisone—ABCB1—Mitoxantrone—lymphatic system cancer	0.0345	0.0449	CbGbCtD
Hydrocortisone—CYP3A4—Cytarabine—lymphatic system cancer	0.03	0.0391	CbGbCtD
Hydrocortisone—CYP3A4—Teniposide—lymphatic system cancer	0.0295	0.0385	CbGbCtD
Hydrocortisone—ABCB1—Vincristine—lymphatic system cancer	0.0237	0.0309	CbGbCtD
Hydrocortisone—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0206	0.0269	CbGbCtD
Hydrocortisone—ABCB1—Methotrexate—lymphatic system cancer	0.0144	0.0187	CbGbCtD
Hydrocortisone—CYP3A4—Vincristine—lymphatic system cancer	0.0142	0.0185	CbGbCtD
Hydrocortisone—Sweating increased—Mitoxantrone—lymphatic system cancer	0.000556	0.00239	CcSEcCtD
Hydrocortisone—Petechiae—Methotrexate—lymphatic system cancer	0.000551	0.00236	CcSEcCtD
Hydrocortisone—Oedema—Fludarabine—lymphatic system cancer	0.000545	0.00234	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.000545	0.00234	CcSEcCtD
Hydrocortisone—Infection—Fludarabine—lymphatic system cancer	0.000542	0.00233	CcSEcCtD
Hydrocortisone—Decreased appetite—Teniposide—lymphatic system cancer	0.000539	0.00232	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.000536	0.0023	CcSEcCtD
Hydrocortisone—Vomiting—Mechlorethamine—lymphatic system cancer	0.000535	0.0023	CcSEcCtD
Hydrocortisone—Nervous system disorder—Fludarabine—lymphatic system cancer	0.000535	0.0023	CcSEcCtD
Hydrocortisone—Rash—Mechlorethamine—lymphatic system cancer	0.00053	0.00228	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.00053	0.00228	CcSEcCtD
Hydrocortisone—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00053	0.00228	CcSEcCtD
Hydrocortisone—Weight decreased—Vincristine—lymphatic system cancer	0.00053	0.00228	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.000527	0.00226	CcSEcCtD
Hydrocortisone—Anorexia—Fludarabine—lymphatic system cancer	0.00052	0.00223	CcSEcCtD
Hydrocortisone—Weight increased—Mitoxantrone—lymphatic system cancer	0.000519	0.00223	CcSEcCtD
Hydrocortisone—Weight decreased—Mitoxantrone—lymphatic system cancer	0.000516	0.00222	CcSEcCtD
Hydrocortisone—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.000515	0.00221	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.000512	0.0022	CcSEcCtD
Hydrocortisone—Myocardial infarction—Vincristine—lymphatic system cancer	0.000512	0.0022	CcSEcCtD
Hydrocortisone—Feeling abnormal—Teniposide—lymphatic system cancer	0.000511	0.0022	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.000507	0.00218	CcSEcCtD
Hydrocortisone—Skin discolouration—Methotrexate—lymphatic system cancer	0.000501	0.00215	CcSEcCtD
Hydrocortisone—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.000501	0.00215	CcSEcCtD
Hydrocortisone—Nausea—Mechlorethamine—lymphatic system cancer	0.0005	0.00215	CcSEcCtD
Hydrocortisone—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.000498	0.00214	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.000497	0.00213	CcSEcCtD
Hydrocortisone—Haemoglobin—Carmustine—lymphatic system cancer	0.000494	0.00212	CcSEcCtD
Hydrocortisone—Urticaria—Teniposide—lymphatic system cancer	0.000493	0.00212	CcSEcCtD
Hydrocortisone—Haemorrhage—Carmustine—lymphatic system cancer	0.000491	0.00211	CcSEcCtD
Hydrocortisone—Body temperature increased—Teniposide—lymphatic system cancer	0.00049	0.00211	CcSEcCtD
Hydrocortisone—Abdominal pain—Teniposide—lymphatic system cancer	0.00049	0.00211	CcSEcCtD
Hydrocortisone—Erythema—Bleomycin—lymphatic system cancer	0.00049	0.0021	CcSEcCtD
Hydrocortisone—Paraesthesia—Fludarabine—lymphatic system cancer	0.000489	0.0021	CcSEcCtD
Hydrocortisone—Hallucination—Carmustine—lymphatic system cancer	0.000489	0.0021	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Carmustine—lymphatic system cancer	0.000483	0.00207	CcSEcCtD
Hydrocortisone—Dyspepsia—Fludarabine—lymphatic system cancer	0.00048	0.00206	CcSEcCtD
Hydrocortisone—Decreased appetite—Fludarabine—lymphatic system cancer	0.000474	0.00204	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.000471	0.00202	CcSEcCtD
Hydrocortisone—Fatigue—Fludarabine—lymphatic system cancer	0.00047	0.00202	CcSEcCtD
Hydrocortisone—Inflammation—Methotrexate—lymphatic system cancer	0.000467	0.00201	CcSEcCtD
Hydrocortisone—Hallucination—Vincristine—lymphatic system cancer	0.000466	0.002	CcSEcCtD
Hydrocortisone—Pain—Fludarabine—lymphatic system cancer	0.000466	0.002	CcSEcCtD
Hydrocortisone—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000465	0.002	CcSEcCtD
Hydrocortisone—Vasculitis—Methotrexate—lymphatic system cancer	0.000464	0.00199	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Vincristine—lymphatic system cancer	0.000461	0.00198	CcSEcCtD
Hydrocortisone—Eye disorder—Carmustine—lymphatic system cancer	0.000459	0.00197	CcSEcCtD
Hydrocortisone—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000459	0.00197	CcSEcCtD
Hydrocortisone—Hypersensitivity—Teniposide—lymphatic system cancer	0.000457	0.00196	CcSEcCtD
Hydrocortisone—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.000457	0.00196	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000454	0.00195	CcSEcCtD
Hydrocortisone—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000449	0.00193	CcSEcCtD
Hydrocortisone—Asthenia—Teniposide—lymphatic system cancer	0.000445	0.00191	CcSEcCtD
Hydrocortisone—Malaise—Bleomycin—lymphatic system cancer	0.000442	0.0019	CcSEcCtD
Hydrocortisone—Pruritus—Teniposide—lymphatic system cancer	0.000439	0.00188	CcSEcCtD
Hydrocortisone—Arrhythmia—Carmustine—lymphatic system cancer	0.000439	0.00188	CcSEcCtD
Hydrocortisone—Skin exfoliation—Methotrexate—lymphatic system cancer	0.000432	0.00186	CcSEcCtD
Hydrocortisone—Body temperature increased—Fludarabine—lymphatic system cancer	0.000431	0.00185	CcSEcCtD
Hydrocortisone—Mental disorder—Carmustine—lymphatic system cancer	0.00043	0.00185	CcSEcCtD
Hydrocortisone—Erythema—Carmustine—lymphatic system cancer	0.000427	0.00184	CcSEcCtD
Hydrocortisone—Malnutrition—Carmustine—lymphatic system cancer	0.000427	0.00184	CcSEcCtD
Hydrocortisone—Diarrhoea—Teniposide—lymphatic system cancer	0.000424	0.00182	CcSEcCtD
Hydrocortisone—Myalgia—Bleomycin—lymphatic system cancer	0.000417	0.00179	CcSEcCtD
Hydrocortisone—Discomfort—Bleomycin—lymphatic system cancer	0.000412	0.00177	CcSEcCtD
Hydrocortisone—Mental disorder—Vincristine—lymphatic system cancer	0.000411	0.00176	CcSEcCtD
Hydrocortisone—Ecchymosis—Methotrexate—lymphatic system cancer	0.00041	0.00176	CcSEcCtD
Hydrocortisone—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000408	0.00175	CcSEcCtD
Hydrocortisone—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.000403	0.00173	CcSEcCtD
Hydrocortisone—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000402	0.00173	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.0004	0.00172	CcSEcCtD
Hydrocortisone—Oedema—Bleomycin—lymphatic system cancer	0.0004	0.00172	CcSEcCtD
Hydrocortisone—Erythema—Mitoxantrone—lymphatic system cancer	0.000397	0.00171	CcSEcCtD
Hydrocortisone—Infection—Bleomycin—lymphatic system cancer	0.000397	0.00171	CcSEcCtD
Hydrocortisone—Vomiting—Teniposide—lymphatic system cancer	0.000394	0.00169	CcSEcCtD
Hydrocortisone—Asthenia—Fludarabine—lymphatic system cancer	0.000391	0.00168	CcSEcCtD
Hydrocortisone—Rash—Teniposide—lymphatic system cancer	0.000391	0.00168	CcSEcCtD
Hydrocortisone—Dermatitis—Teniposide—lymphatic system cancer	0.000391	0.00168	CcSEcCtD
Hydrocortisone—Headache—Teniposide—lymphatic system cancer	0.000389	0.00167	CcSEcCtD
Hydrocortisone—Pruritus—Fludarabine—lymphatic system cancer	0.000386	0.00166	CcSEcCtD
Hydrocortisone—Anorexia—Bleomycin—lymphatic system cancer	0.000381	0.00164	CcSEcCtD
Hydrocortisone—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00038	0.00163	CcSEcCtD
Hydrocortisone—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000378	0.00162	CcSEcCtD
Hydrocortisone—Hypotension—Bleomycin—lymphatic system cancer	0.000373	0.0016	CcSEcCtD
Hydrocortisone—Diarrhoea—Fludarabine—lymphatic system cancer	0.000373	0.0016	CcSEcCtD
Hydrocortisone—Convulsion—Carmustine—lymphatic system cancer	0.00037	0.00159	CcSEcCtD
Hydrocortisone—Hypertension—Carmustine—lymphatic system cancer	0.000369	0.00159	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000369	0.00158	CcSEcCtD
Hydrocortisone—Nausea—Teniposide—lymphatic system cancer	0.000368	0.00158	CcSEcCtD
Hydrocortisone—Vertigo—Vincristine—lymphatic system cancer	0.000367	0.00157	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000364	0.00156	CcSEcCtD
Hydrocortisone—Myalgia—Carmustine—lymphatic system cancer	0.000364	0.00156	CcSEcCtD
Hydrocortisone—Anxiety—Carmustine—lymphatic system cancer	0.000363	0.00156	CcSEcCtD
Hydrocortisone—Paraesthesia—Bleomycin—lymphatic system cancer	0.000359	0.00154	CcSEcCtD
Hydrocortisone—Malaise—Mitoxantrone—lymphatic system cancer	0.000358	0.00154	CcSEcCtD
Hydrocortisone—Convulsion—Vincristine—lymphatic system cancer	0.000354	0.00152	CcSEcCtD
Hydrocortisone—Hypertension—Vincristine—lymphatic system cancer	0.000352	0.00151	CcSEcCtD
Hydrocortisone—Oedema—Carmustine—lymphatic system cancer	0.000349	0.0015	CcSEcCtD
Hydrocortisone—Decreased appetite—Bleomycin—lymphatic system cancer	0.000347	0.00149	CcSEcCtD
Hydrocortisone—Myalgia—Vincristine—lymphatic system cancer	0.000347	0.00149	CcSEcCtD
Hydrocortisone—Infection—Carmustine—lymphatic system cancer	0.000347	0.00149	CcSEcCtD
Hydrocortisone—Vomiting—Fludarabine—lymphatic system cancer	0.000347	0.00149	CcSEcCtD
Hydrocortisone—Convulsion—Mitoxantrone—lymphatic system cancer	0.000344	0.00148	CcSEcCtD
Hydrocortisone—Rash—Fludarabine—lymphatic system cancer	0.000344	0.00148	CcSEcCtD
Hydrocortisone—Dermatitis—Fludarabine—lymphatic system cancer	0.000343	0.00148	CcSEcCtD
Hydrocortisone—Hypertension—Mitoxantrone—lymphatic system cancer	0.000343	0.00147	CcSEcCtD
Hydrocortisone—Pain—Bleomycin—lymphatic system cancer	0.000342	0.00147	CcSEcCtD
Hydrocortisone—Headache—Fludarabine—lymphatic system cancer	0.000342	0.00147	CcSEcCtD
Hydrocortisone—Tachycardia—Carmustine—lymphatic system cancer	0.000341	0.00146	CcSEcCtD
Hydrocortisone—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00034	0.00146	CcSEcCtD
Hydrocortisone—Myalgia—Mitoxantrone—lymphatic system cancer	0.000338	0.00145	CcSEcCtD
Hydrocortisone—Anxiety—Mitoxantrone—lymphatic system cancer	0.000337	0.00145	CcSEcCtD
Hydrocortisone—Lethargy—Methotrexate—lymphatic system cancer	0.000336	0.00144	CcSEcCtD
Hydrocortisone—Discomfort—Mitoxantrone—lymphatic system cancer	0.000334	0.00144	CcSEcCtD
Hydrocortisone—Oedema—Vincristine—lymphatic system cancer	0.000333	0.00143	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000333	0.00143	CcSEcCtD
Hydrocortisone—Anorexia—Carmustine—lymphatic system cancer	0.000333	0.00143	CcSEcCtD
Hydrocortisone—Infection—Vincristine—lymphatic system cancer	0.000331	0.00142	CcSEcCtD
Hydrocortisone—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000329	0.00141	CcSEcCtD
Hydrocortisone—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000329	0.00141	CcSEcCtD
Hydrocortisone—Nervous system disorder—Vincristine—lymphatic system cancer	0.000327	0.0014	CcSEcCtD
Hydrocortisone—Hypotension—Carmustine—lymphatic system cancer	0.000326	0.0014	CcSEcCtD
Hydrocortisone—Oedema—Mitoxantrone—lymphatic system cancer	0.000324	0.00139	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000324	0.00139	CcSEcCtD
Hydrocortisone—Nausea—Fludarabine—lymphatic system cancer	0.000324	0.00139	CcSEcCtD
Hydrocortisone—Infection—Mitoxantrone—lymphatic system cancer	0.000322	0.00138	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000322	0.00138	CcSEcCtD
Hydrocortisone—Shock—Mitoxantrone—lymphatic system cancer	0.000319	0.00137	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000318	0.00137	CcSEcCtD
Hydrocortisone—Urticaria—Bleomycin—lymphatic system cancer	0.000318	0.00136	CcSEcCtD
Hydrocortisone—Anorexia—Vincristine—lymphatic system cancer	0.000317	0.00136	CcSEcCtD
Hydrocortisone—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000317	0.00136	CcSEcCtD
Hydrocortisone—Body temperature increased—Bleomycin—lymphatic system cancer	0.000316	0.00136	CcSEcCtD
Hydrocortisone—Insomnia—Carmustine—lymphatic system cancer	0.000316	0.00136	CcSEcCtD
Hydrocortisone—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000315	0.00135	CcSEcCtD
Hydrocortisone—Irritability—Methotrexate—lymphatic system cancer	0.000314	0.00135	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000314	0.00135	CcSEcCtD
Hydrocortisone—Paraesthesia—Carmustine—lymphatic system cancer	0.000313	0.00135	CcSEcCtD
Hydrocortisone—Mood swings—Methotrexate—lymphatic system cancer	0.000311	0.00134	CcSEcCtD
Hydrocortisone—Hypotension—Vincristine—lymphatic system cancer	0.000311	0.00134	CcSEcCtD
Hydrocortisone—Anorexia—Mitoxantrone—lymphatic system cancer	0.000309	0.00133	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000303	0.0013	CcSEcCtD
Hydrocortisone—Decreased appetite—Carmustine—lymphatic system cancer	0.000303	0.0013	CcSEcCtD
Hydrocortisone—Hypotension—Mitoxantrone—lymphatic system cancer	0.000303	0.0013	CcSEcCtD
Hydrocortisone—Insomnia—Vincristine—lymphatic system cancer	0.000301	0.00129	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000301	0.00129	CcSEcCtD
Hydrocortisone—Paraesthesia—Vincristine—lymphatic system cancer	0.000299	0.00128	CcSEcCtD
Hydrocortisone—Pain—Carmustine—lymphatic system cancer	0.000298	0.00128	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000296	0.00127	CcSEcCtD
Hydrocortisone—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000294	0.00126	CcSEcCtD
Hydrocortisone—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000291	0.00125	CcSEcCtD
Hydrocortisone—Decreased appetite—Vincristine—lymphatic system cancer	0.00029	0.00124	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000288	0.00124	CcSEcCtD
Hydrocortisone—Feeling abnormal—Carmustine—lymphatic system cancer	0.000288	0.00123	CcSEcCtD
Hydrocortisone—Fatigue—Vincristine—lymphatic system cancer	0.000287	0.00123	CcSEcCtD
Hydrocortisone—Asthenia—Bleomycin—lymphatic system cancer	0.000287	0.00123	CcSEcCtD
Hydrocortisone—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000286	0.00123	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000285	0.00123	CcSEcCtD
Hydrocortisone—Pain—Vincristine—lymphatic system cancer	0.000285	0.00122	CcSEcCtD
Hydrocortisone—Pruritus—Bleomycin—lymphatic system cancer	0.000283	0.00121	CcSEcCtD
Hydrocortisone—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000282	0.00121	CcSEcCtD
Hydrocortisone—Fatigue—Mitoxantrone—lymphatic system cancer	0.00028	0.0012	CcSEcCtD
Hydrocortisone—Pancreatitis—Methotrexate—lymphatic system cancer	0.000279	0.0012	CcSEcCtD
Hydrocortisone—Pain—Mitoxantrone—lymphatic system cancer	0.000277	0.00119	CcSEcCtD
Hydrocortisone—Body temperature increased—Carmustine—lymphatic system cancer	0.000276	0.00118	CcSEcCtD
Hydrocortisone—Abdominal pain—Carmustine—lymphatic system cancer	0.000276	0.00118	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000272	0.00117	CcSEcCtD
Hydrocortisone—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000267	0.00115	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000265	0.00114	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000264	0.00113	CcSEcCtD
Hydrocortisone—Abdominal pain—Vincristine—lymphatic system cancer	0.000263	0.00113	CcSEcCtD
Hydrocortisone—Body temperature increased—Vincristine—lymphatic system cancer	0.000263	0.00113	CcSEcCtD
Hydrocortisone—Urticaria—Mitoxantrone—lymphatic system cancer	0.000258	0.00111	CcSEcCtD
Hydrocortisone—Hypersensitivity—Carmustine—lymphatic system cancer	0.000257	0.0011	CcSEcCtD
Hydrocortisone—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000256	0.0011	CcSEcCtD
Hydrocortisone—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000256	0.0011	CcSEcCtD
Hydrocortisone—Vomiting—Bleomycin—lymphatic system cancer	0.000254	0.00109	CcSEcCtD
Hydrocortisone—Infestation—Methotrexate—lymphatic system cancer	0.000253	0.00109	CcSEcCtD
Hydrocortisone—Infestation NOS—Methotrexate—lymphatic system cancer	0.000253	0.00109	CcSEcCtD
Hydrocortisone—Rash—Bleomycin—lymphatic system cancer	0.000252	0.00108	CcSEcCtD
Hydrocortisone—Dermatitis—Bleomycin—lymphatic system cancer	0.000252	0.00108	CcSEcCtD
Hydrocortisone—Asthenia—Carmustine—lymphatic system cancer	0.00025	0.00108	CcSEcCtD
Hydrocortisone—Hypersensitivity—Vincristine—lymphatic system cancer	0.000245	0.00105	CcSEcCtD
Hydrocortisone—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000239	0.00103	CcSEcCtD
Hydrocortisone—Asthenia—Vincristine—lymphatic system cancer	0.000239	0.00103	CcSEcCtD
Hydrocortisone—Diarrhoea—Carmustine—lymphatic system cancer	0.000239	0.00103	CcSEcCtD
Hydrocortisone—Nausea—Bleomycin—lymphatic system cancer	0.000237	0.00102	CcSEcCtD
Hydrocortisone—Asthenia—Mitoxantrone—lymphatic system cancer	0.000233	0.001	CcSEcCtD
Hydrocortisone—Dizziness—Carmustine—lymphatic system cancer	0.000231	0.000991	CcSEcCtD
Hydrocortisone—Haemoglobin—Methotrexate—lymphatic system cancer	0.000229	0.000982	CcSEcCtD
Hydrocortisone—Diarrhoea—Vincristine—lymphatic system cancer	0.000228	0.000979	CcSEcCtD
Hydrocortisone—Haemorrhage—Methotrexate—lymphatic system cancer	0.000227	0.000977	CcSEcCtD
Hydrocortisone—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000222	0.000953	CcSEcCtD
Hydrocortisone—Vomiting—Carmustine—lymphatic system cancer	0.000222	0.000953	CcSEcCtD
Hydrocortisone—Dizziness—Vincristine—lymphatic system cancer	0.00022	0.000946	CcSEcCtD
Hydrocortisone—Rash—Carmustine—lymphatic system cancer	0.00022	0.000945	CcSEcCtD
Hydrocortisone—Dermatitis—Carmustine—lymphatic system cancer	0.00022	0.000944	CcSEcCtD
Hydrocortisone—Headache—Carmustine—lymphatic system cancer	0.000219	0.000939	CcSEcCtD
Hydrocortisone—Eye disorder—Methotrexate—lymphatic system cancer	0.000213	0.000913	CcSEcCtD
Hydrocortisone—Vomiting—Vincristine—lymphatic system cancer	0.000212	0.00091	CcSEcCtD
Hydrocortisone—Rash—Vincristine—lymphatic system cancer	0.00021	0.000902	CcSEcCtD
Hydrocortisone—Dermatitis—Vincristine—lymphatic system cancer	0.00021	0.000901	CcSEcCtD
Hydrocortisone—Headache—Vincristine—lymphatic system cancer	0.000209	0.000896	CcSEcCtD
Hydrocortisone—Nausea—Carmustine—lymphatic system cancer	0.000207	0.00089	CcSEcCtD
Hydrocortisone—Vomiting—Mitoxantrone—lymphatic system cancer	0.000206	0.000886	CcSEcCtD
Hydrocortisone—Immune system disorder—Methotrexate—lymphatic system cancer	0.000205	0.000882	CcSEcCtD
Hydrocortisone—Rash—Mitoxantrone—lymphatic system cancer	0.000205	0.000878	CcSEcCtD
Hydrocortisone—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000204	0.000878	CcSEcCtD
Hydrocortisone—Headache—Mitoxantrone—lymphatic system cancer	0.000203	0.000873	CcSEcCtD
Hydrocortisone—Mental disorder—Methotrexate—lymphatic system cancer	0.000199	0.000856	CcSEcCtD
Hydrocortisone—Erythema—Methotrexate—lymphatic system cancer	0.000198	0.000851	CcSEcCtD
Hydrocortisone—Malnutrition—Methotrexate—lymphatic system cancer	0.000198	0.000851	CcSEcCtD
Hydrocortisone—Nausea—Vincristine—lymphatic system cancer	0.000198	0.00085	CcSEcCtD
Hydrocortisone—Nausea—Mitoxantrone—lymphatic system cancer	0.000193	0.000828	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000184	0.000789	CcSEcCtD
Hydrocortisone—Malaise—Methotrexate—lymphatic system cancer	0.000179	0.000767	CcSEcCtD
Hydrocortisone—Vertigo—Methotrexate—lymphatic system cancer	0.000178	0.000764	CcSEcCtD
Hydrocortisone—Convulsion—Methotrexate—lymphatic system cancer	0.000172	0.000737	CcSEcCtD
Hydrocortisone—Myalgia—Methotrexate—lymphatic system cancer	0.000169	0.000724	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000167	0.000719	CcSEcCtD
Hydrocortisone—Discomfort—Methotrexate—lymphatic system cancer	0.000167	0.000715	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000162	0.000694	CcSEcCtD
Hydrocortisone—Infection—Methotrexate—lymphatic system cancer	0.000161	0.00069	CcSEcCtD
Hydrocortisone—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000158	0.000681	CcSEcCtD
Hydrocortisone—Skin disorder—Methotrexate—lymphatic system cancer	0.000157	0.000674	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000156	0.000671	CcSEcCtD
Hydrocortisone—Anorexia—Methotrexate—lymphatic system cancer	0.000154	0.000662	CcSEcCtD
Hydrocortisone—Hypotension—Methotrexate—lymphatic system cancer	0.000151	0.000649	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000147	0.000632	CcSEcCtD
Hydrocortisone—Insomnia—Methotrexate—lymphatic system cancer	0.000146	0.000628	CcSEcCtD
Hydrocortisone—Paraesthesia—Methotrexate—lymphatic system cancer	0.000145	0.000623	CcSEcCtD
Hydrocortisone—Dyspepsia—Methotrexate—lymphatic system cancer	0.000142	0.000611	CcSEcCtD
Hydrocortisone—Decreased appetite—Methotrexate—lymphatic system cancer	0.00014	0.000603	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00014	0.000599	CcSEcCtD
Hydrocortisone—Fatigue—Methotrexate—lymphatic system cancer	0.000139	0.000598	CcSEcCtD
Hydrocortisone—Pain—Methotrexate—lymphatic system cancer	0.000138	0.000594	CcSEcCtD
Hydrocortisone—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000133	0.000572	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000132	0.000568	CcSEcCtD
Hydrocortisone—Urticaria—Methotrexate—lymphatic system cancer	0.000128	0.000551	CcSEcCtD
Hydrocortisone—Abdominal pain—Methotrexate—lymphatic system cancer	0.000128	0.000549	CcSEcCtD
Hydrocortisone—Body temperature increased—Methotrexate—lymphatic system cancer	0.000128	0.000549	CcSEcCtD
Hydrocortisone—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000119	0.000511	CcSEcCtD
Hydrocortisone—Asthenia—Methotrexate—lymphatic system cancer	0.000116	0.000498	CcSEcCtD
Hydrocortisone—Pruritus—Methotrexate—lymphatic system cancer	0.000114	0.000491	CcSEcCtD
Hydrocortisone—Diarrhoea—Methotrexate—lymphatic system cancer	0.000111	0.000475	CcSEcCtD
Hydrocortisone—Dizziness—Methotrexate—lymphatic system cancer	0.000107	0.000459	CcSEcCtD
Hydrocortisone—Vomiting—Methotrexate—lymphatic system cancer	0.000103	0.000441	CcSEcCtD
Hydrocortisone—Rash—Methotrexate—lymphatic system cancer	0.000102	0.000438	CcSEcCtD
Hydrocortisone—Dermatitis—Methotrexate—lymphatic system cancer	0.000102	0.000437	CcSEcCtD
Hydrocortisone—Headache—Methotrexate—lymphatic system cancer	0.000101	0.000435	CcSEcCtD
Hydrocortisone—Nausea—Methotrexate—lymphatic system cancer	9.6e-05	0.000412	CcSEcCtD
